Amgen drug misses endpoint in acute heart failure trialPMLiVEA drug in development by Amgen and Cytokinetics to treat symptoms of heart failure has missed its primary endpoint in a phase II trial. During the ATOMIC-AHF trial involving 613 patients with…
More data backs Novartis' serelaxin in heart failure – PMLiVE
Business Recorder |
More data backs Novartis’ serelaxin in heart failure
PMLiVE Momentum continues to build behind Novartis’ heart failure candidate serelaxin, with new data from the European Society of Cardiology (ESC) meeting cementing its position as a blockbuster-in-waiting. A new analysis of data from the RELAX-AHF study has … Novartis heart failure drug effective across patient groupsReuters India Novartis’ serelaxin (RLX030) improved symptoms and mortality across multiple …ITNews Efficacy Of Novartis AG (ADR) (NYSE:NVS) For Heart FailuresPR Carbon (press release) |
Battling Kala azar: Indian scientists overcoming drug resistance – Business Standard
|
Battling Kala azar: Indian scientists overcoming drug resistance
Business Standard What was of interest to scientists was that the Leishmania parasite (that infects the liver and multiplies in the spleen) brings down the miRNA levels by “targeting an enzyme called dicer that is responsible for the production of these micro regulators … |
Rob Newman's rules of the road Three tips for touring – Chortle
|
Rob Newman’s rules of the road Three tips for touring
Chortle So, how do you prevent autopilot brain death? How do you snap out of it? How do you get back into the moment, all present and correct? I’ve asked around. Harry Hill once told me that if he ever feels this out-of-body experience creeping up on him … |
ADCB employees brighten lives through blood donation drive – AME Info (press release)
ADCB employees brighten lives through blood donation driveAME Info (press release)Abu Dhabi Commercial Bank (ADCB) recently held a blood donation drive at its Head Office in Abu Dhabi. A large number of employees from various divisions of the bank turn…
Hot Line IV: Late-breaking trials on heart failure and acute coronary syndrome – Medical Xpress
Hot Line IV: Late-breaking trials on heart failure and acute coronary syndromeMedical XpressThe blood pressure lowering drug aliskiren did not improve coronary artery disease when given to patients who had prehypertension, results of the Aliskiren Quan…
Organ trafficking: a protected crime – The Conversation
Organ trafficking: a protected crimeThe Conversation… transplant surgeries have infiltrated global medical practice. But despite the evidence of widespread criminal networks and several limited prosecutions in countries including India, Kosovo, Turke…
Passing on the Right Antibodies: Protecting Piglets from Diarrhoea – ThePigSite.com
Passing on the Right Antibodies: Protecting Piglets from DiarrhoeaThePigSite.comAUSTRIA – The parasite Cystoisospora suis affects suckling pigs causing severe intestinal problems, such as diarrhoea. Scientists at the University of Veterinary Medicine, …
SERVE-HF; the World's Largest Study of Sleep-Disordered Breathing in Heart … – PR Newswire (press release)
|
SERVE-HF; the World’s Largest Study of Sleep-Disordered Breathing in Heart …
PR Newswire (press release) Approximately 14 million people in Europe are living with heart failure2 and central sleep-disordered breathing is known to be a highly prevalent comorbidity in these patients. With an estimated 30-50 percent of heart failure patients potentially at … |
Hot Line IV: Late-breaking trials on heart failure and acute coronary syndrome – EurekAlert (press release)
|
Hot Line IV: Late-breaking trials on heart failure and acute coronary syndrome
EurekAlert (press release) AMSTERDAM, The Netherlands – The blood pressure lowering drug aliskiren did not improve coronary artery disease when given to patients who had prehypertension, results of the Aliskiren Quantitative Atherosclerosis Regression Intravascular Ultrasound … |